Theodore Bross, MD
Family Practice · Westminster, CONPI 1750886131
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 25.8% of the total. Among family practice clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$419
- Lilly USA, LLC$135
- Pfizer$121
- AstraZeneca$96
- Bausch Health US, LLC$90
- GSK$80
- plus $683 from 17 others
What the payments were for
- Food & beverage$1,624100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $419 |
| Lilly USA, LLC | 9 | $135 |
| Pfizer | 7 | $121 |
| AstraZeneca | 6 | $96 |
| Bausch Health US, LLC | 4 | $90 |
| GSK | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Astellas Pharma US Inc | 3 | $68 |
| Novo Nordisk | 3 | $63 |
| Amgen | 3 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Boston Scientific | 2 | $32 |
| Eisai Inc. | 2 | $30 |
| Novartis | 1 | $29 |
| Exact Sciences | 1 | $29 |
| Nestle Healthcare Nutrition Inc. | 2 | $27 |
| Merck | 1 | $22 |
| Exeltis, USA Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Grifols USA, LLC | 1 | $12 |
How this compares
$1,624 in reported general payments places this provider in the 95th percentile of 428 family practice providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $92,768 |
| XareltoRivaroxaban | 15 | $23,969 |
| JardianceEmpagliflozin | 12 | $20,423 |
| FarxigaDapagliflozin Propanediol | 11 | $18,753 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $16,154 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,199 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 18 | $3,964 |
| Rosuvastatin Calcium | 209 | $2,470 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 28 | $1,984 |
| SynthroidLevothyroxine Sodium | 28 | $1,639 |
| Gabapentin | 90 | $1,481 |
| Tamsulosin Hcl | 137 | $1,412 |
| Atorvastatin Calcium | 200 | $1,281 |
| Ezetimibe | 65 | $1,241 |
| Levothyroxine Sodium | 128 | $1,086 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $121 | $92,76868 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $96 | $34,90729 claims |
| GSKAnoro Ellipta, Shingrix | $80 | $9,16429 claims |
| AbbVieSynthroid | $419 | $1,63928 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 428 family practice providers in Colorado.
Other family practice in Westminster
- Torri IgouWestminster$32
- Matthew LudemannWestminster$0
- Lindsey SchafferWestminster$0
- Celeste DeanDenver$3K
- Eric KimDenver$893
- Nicolas GambleDenver$781
- Lora ShirarGolden$0
- Matthew NowlandYuma$0
- Michael DeweyBroomfield$0
- Melanie RauscheDenver$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.